埃博拉病毒感染流行区埃博拉病毒感染与听力损失的关联:一项系统综述
本系统综述检索1965年1月1日至2018年10月1日PubMed、Embase和Google Scholar的英文文献,纳入15项研究(3项回顾性病例对照研究为证据3级,12项横断面研究或病例报告为证据4级),共1775例埃博拉病毒感染幸存者(女性993例,55.9%)和363例未感染对照(女性186例,51.2%)。幸存者听力损失报告率为8.3%(147例);在比较幸存者与对照的研究中,幸存者听力损失的比值比为7.50(95%CI 3.91-14.39),纳入所有研究后流行区幸存者与对照的比值比为1.84(95%CI 1.10-3.08)。
要点
- 埃博拉病毒感染幸存者听力损失报告率为8.3%(147/1775)。
- 比较幸存者与对照的研究中,听力损失比值比为7.50(95%CI 3.91-14.39)。
- 流行区所有研究中幸存者与对照的听力损失比值比为1.84(95%CI 1.10-3.08)。
核心结论
- 在埃博拉病毒感染流行区,埃博拉病毒感染幸存者的听力损失率高于未感染对照。
- 可能需要采用一致的客观方法和纯音测听开展进一步研究,以更好地描述听力损失特征、理解其病理生理特点并开发治疗方法。
研究设计与样本
- 系统综述,遵循PRISMA报告指南相关部分。
- 检索PubMed、Embase和Google Scholar,纳入1965年1月1日至2018年10月1日发表的英文文献。
- 两位研究者独立筛选合格研究、提取数据并评估质量与偏倚风险。
- 共审查127篇文献,15篇符合纳入标准:3项回顾性病例对照研究(证据级别3),12项横断面研究或病例报告(证据级别4)。
- 纳入1775例埃博拉病毒感染幸存者(女性993例,55.9%)和363例未感染对照(女性186例,51.2%),来自刚果民主共和国、乌干达、几内亚、利比里亚和塞拉利昂。
主要发现
- 147例埃博拉病毒感染幸存者报告听力损失(8.3%)。
- 在比较幸存者与对照的研究中,幸存者听力损失的比值比为7.50(95%CI 3.91-14.39;范围1.4-12.1)。
- 纳入所有研究,在埃博拉病毒感染流行区,幸存者与对照听力损失的比值比为1.84(95%CI 1.10-3.08)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 可能需要采用一致的客观方法和纯音测听开展进一步研究,以更好地描述听力损失特征、理解其病理生理特点并开发治疗方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Many survivors of Ebola virus infection describe new-onset hearing loss after infection. The prevalence, severity, and pathophysiologic features of hearing loss in this population have not been well characterized. OBJECTIVE: To perform a systematic review of the current literature to characterize hearing loss in survivors of Ebola virus infection. EVIDENCE REVIEW: This study adhered to the relevant sections of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Searches through PubMed, Embase, and Google Scholar were performed to include publications written in English from January 1, 1965, to October 1, 2018. Relevant vocabulary terms and key terms related to Ebola and hearing loss were used. Two investigators independently screened the eligible studies, extracted data, and assessed quality and risk of bias. FINDINGS: Of 127 publications reviewed, 15 met the criteria for inclusion; 3 were retrospective case-control studies (level of evidence, 3), and 12 were cross-sectional studies or case reports (level of evidence, 4). Studies included 1775 survivors of Ebola virus infection (993 female [55.9%]) and 363 uninfected controls (186 female [51.2%]) from the Democratic Republic of the Congo, Uganda, Guinea, Liberia, and Sierra Leone. The duration of follow-up ranged from 0 to 29 months (median, 5 months). Hearing loss was reported in 147 survivors of Ebola virus infection (8.3%). Among studies that compared survivors with controls, the reported odds ratios for hearing loss in survivors was 7.50 (95% CI, 3.91-14.39; range, 1.4-12.1). Including all studies, the odds ratio of hearing loss in survivors vs controls in countries where Ebola virus infection is endemic was 1.84 (95% CI, 1.10-3.08). CONCLUSIONS AND RELEVANCE: Survivors of Ebola virus infection had higher rates of hearing loss than uninfected controls in regions where the infection is endemic. Further research with consistent objective methods and pure-tone audiometry may be needed to better characterize the hearing loss, understand its pathophysiologic features, and develop treatments.
引用
- Xu MJ, Stanford-Moore G, Czechowicz JA, et al. Association of Ebola Virus Infection With Hearing Loss in Regions Where Ebola Virus Infection Is Endemic: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31095264. doi:10.1001/jamaoto.2019.0710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。